期刊文献+

A型肉毒毒素局部注射治疗脑卒中后上肢屈肌痉挛 被引量:6

Effect of local injection of botulismotoxin-A on spasticity of the upper limb flexor after stroke
在线阅读 下载PDF
导出
摘要 目的:探讨A型肉毒毒素局部注射治疗脑卒中后上肢屈肌痉挛的疗效。方法:选择12例脑卒中后遗症期的患者,均有偏瘫侧上肢屈肌张力明显增高,改良的Ashworth量表评分Ⅱ~Ⅲ级,肘关节活动范围受限,影响患者日常生活能力。根据患者的具体情况,使用不同剂量的肉毒毒素(100~150单位)稀释后分6~8点患侧肱二头肌局部注射,在注射后2,4,12周时,分别进行痉挛和关节活动范围的再评估,进行比较。结果:A型肉毒毒素局部注射治疗后2,4,12周患者肱二头肌痉挛程度分别为1.7±0.6,1.4±0.4,1.6±0.5均较注射前2.6±0.8显著改善(P<0.05)。患者的关节主动、被动活动范围在注射2,4,12周后较注射前亦有显著增加,分别为(124.2±14.6)°,(126.8±10.5)°,(123.8±7.6)°和(108.6±12.1)°,(107.4±13.2)°,(103.2±8.6)°(P<0.05)。结论:A型肉毒毒素局部注射治疗脑卒中后上肢屈肌痉挛具有较好的疗效。 AIM:To explore the effect of local injection of botulismotoxin A on spasticity of the upper limb flexor after stroke. METHODS:Twelve patients with hemiplegia after stroke were selected.All patients had apparent increase of upper limb flexor muscular tension,modified Ashworth scale ranged 2-3 degree and limit of elbow joint range of motion,which influenced the ability of daily life.Different doses of botulismotoxin A(100-150 units) were injected to the biceps brachii muscle of the patients on 6-8 points after dilution according to the their conditions.The degree of spasticity and range of elbow joint motion were evaluated at the 2nd,4th,12th weeks after injection,compared with those of preinjection. RESULTS:The degree of spasticity of biceps brachii muscle at the 2nd,4th,12th weeks after injection(1.7±0.6,1.4±0.4,1.6±0.5) were significantly improved compared with that of preinjection(2.6±0.8)(P< 0.05).The active[(124.2±14.6)°,(126.8±10.5)°,(123.8±7.6)°and passive[108.6±12.1)°,(107.4±13.2)°,(103.2±8.6)°] range of elbow joint motion after 2th,4th,12th weeks were also significantly increased(P< 0.05). CONCLUSION:Local injection of botulismotoxin A has a better effect on spasticity of the upper limb flexor after stroke.
出处 《中国临床康复》 CSCD 2004年第1期12-13,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献4

二级参考文献38

  • 1孙洁民,陈琦,王淑凤.儿童肌痉挛治疗进展[J].中国组织工程研究与临床康复,2001,10(12):52-53. 被引量:2
  • 2马若飞,齐有为.小儿脑瘫的治疗和评估标准探讨[J].现代康复,1999,3(2):176-177. 被引量:113
  • 3林庆.全国小儿脑性瘫疾座谈会记要[J].中华儿科杂志,1989,27(3):162-164.
  • 4KOMAN LA, MOONEY JF, SMITH B, et al. Management of cerebral palsy with botulinum-A toxin: Preliminary investigation[J]. Jour Pediatr Orthop,1993,13(4):489-495.
  • 5SANCHEZ CARPINLERO R,NARBONA J.Botulinum toxin in spastic infantile cerebral palsy results in 27 cases during one year[J]. Rev Neurol,1997,25(140):531-535.
  • 6BUCHMAN AS,COMELL CI,STEBBINS GT,et al.Quantitative electromyographic analysis in muscle activity following botulinum toxin therapy for cervical dystonisa[J].Clin Neuropharmacol,1993,16:205-210.
  • 7SCHANTZ EJ, JOHNSON EA.Properties and use of botulinum toxin and other microbial neurotoxins in medicine[J]. Microbiol Rev,1992,56(1):80-81.
  • 8SCOTT AB.Botulinum toxin injection of eye muscle to correct strabismuss[J].Tr Am Ophthalmol Soc,1981,79:735.
  • 9GREENE P,KANG U,FAHN S,et al.Double-blind controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis[J].Neurology,1990,40:1213.
  • 10WADE DT.Measurement in Neurological Rehabilitation[M].Oxford:Oxford University Press,1996:162.

共引文献28

同被引文献43

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部